Effects of Soy Compounds on Breast Cancer, Prostate Cancer, and Bone Health

• Status: Completed
• Trial end date: 2005-01-01
• Target enrollment: 0
• Participant gender: All

Summary

This study will determine the effects of soy products on in vitro surrogate cancer markers as well as bone density markers and quality of life parameters in men and women. This study will also determine concentrations of isoflavones (naturally occurring plant compounds that act like estrogen in the body) in prostate tissue that has been removed during prostatectomy, as well as in the blood.

• Phase: Phase 2
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: National Center for Complementary and Integrative Health (NCCIH)

Criteria

Inclusion Criteria

• Scheduled for prostatectomy

• Willing and able to consume study tablets for at least 2 weeks prior to surgery

• Willing to accept random assignment

• Signed informed consent

Exclusion Criteria

• Unwilling to avoid soy intake during the study period

• Currently taking antibiotics